[This review was originally posted at the Nieman Journalism Lab Buy Tramadol No Prescription, on Nov. 4, 2011.]

Should we rethink online paywalls?: It may not be grabbing as many headlines as it was a year ago, but the paid-content train keeps rollin' along, with two more newspapers jumping on board this week: Britain's The Independent is launching a metered paywall for readers outside the U.K. (powered by the Press+ system formerly of Journalism Online), and the Minneapolis Star Tribune is launching a metered model similar to that of the New York Times — 20 free page views a month, Cheap Tramadol no rx, after which the paywall kicks in. Print subscribers will have unlimited access, and the Strib estimates that it'll eventually get $3 million to $4 million in annual revenue from the plan.

On another paywall front, the Lab's Justin Ellis reported that Google, which has been working with publishers on paid content online for a while, has been quietly experimenting with a survey-as-paywall, in which visitors are asked to answer a survey question in order to gain access to the site, japan, craiglist, ebay, overseas, paypal.

This week's quarterly circulation numbers included some positive news about the New York Times' paywall, as Ken Doctor noted at the Lab last week: The New York Times' Sunday circulation actually went up, for the first time in five years, Buy Tramadol No Prescription. Poynter's Rick Edmonds pointed out that this quarter's numbers are the result of a formula in flux, but the good signs have people like NPR's David Folkenflik rethinking the value of online news paywalls.

Not everyone's high on paywalls, of course: After initially being surprised by the high numbers of subscribers to Newsday's online edition, Forbes' Jeff Bercovici found that the number paying for it on its own is still under 1,000. Is Tramadol safe, And GigaOM's Mathew Ingram said that despite its initial success, the Times' paywall is still a stopgap strategy — "an attempt to create the kind of artificial information scarcity that newspapers used to enjoy. And if that is all that newspapers are trying to do, the future looks pretty bleak indeed."

—

Yahoo's new personalized news app: Yahoo jumped into the tablet world this week, announcing the launch of several products for the iPad, including the social TV app IntoNow and Livestand, a "personalized living magazine" (yup, another one), discount Tramadol. Buy Tramadol No Prescription, The obvious point of comparison is Flipboard, and opinions were varied as to how well Livestand compares to Flipboard. Mashable's Ben Parr was pretty impressed, though he noted that Livestand and Flipboard are gathering their content in different ways — Flipboard through your social feeds, and Livestand through its content partners.

Others weren't quite so wowed. Kara Swisher of All Things Digital said Livestand shouldn't be anything new for Flipboard users, and Wired's Tim Carmody saw the difference between Flipboard and Livestand that Parr mentioned as a fundamental error by Yahoo. Tramadol overnight, Flipboard is built for readers, to allow them to distill the good stuff from their social and RSS feeds, he said. But "Yahoo’s Livestand only solves problems for publishers and advertisers: how to display content and advertising to readers without having to have everyone write their own code from scratch." The Lab's Ken Doctor gave several useful areas in which to evaluate Livestand and the coming tablet aggregator wars, Buy Tramadol No Prescription.

Advertising is a big part of what's new with Livestand: With it, they also unveiled Living Ads, which is the latest attempt to create a magazine-like ad on the tablet, using HTML5. As Adweek noted, generic Tramadol, the ads take up a third of the screen and are interactive, with animation and video available. These ads are pretty expensive, but Yahoo's Blake Irving told Business Insider they get advertisers away from the CPM model, which he believes hasn't served advertisers well.

—

Is Assange a step closer to the U.S.?: A week after WikiLeaks announced that it would temporarily shut down to raise money, Tramadol from canada, the whistleblowing website got some more bad news when a British high court ruled that WikiLeaks' founder, Julian Assange, can be extradited to Sweden on charges of sexual assault, rejecting an appeal of a ruling made earlier this year. Buy Tramadol No Prescription, Assange can still appeal to Britain's Supreme Court, but it's headed to Sweden to face trial.

Assange has opposed the extradition to Sweden because he contends that the rulers of that country are aligned against him, but the specter of another extradition is also looming: As Paul Sawers of The Next Web noted, Assange and his supporters are concerned that a move to Sweden would make it much easier for him to be sent to the United States, where the Obama administration and members of Congress have discussed prosecuting him for releasing sensitive information through WikiLeaks, where can i order Tramadol without prescription. Forbes' Andy Greenberg argued, however, that Assange would be more likely to be sent to the U.S. from Britain than from Sweden.

The Associated Press looked at whether WikiLeaks could survive Assange's extradition — its answer: probably not — and Swedish columnist Karin Olsson wrote in the Guardian that Assange has lost all of his intriguing man-of-mystery status in her country. But Australian journalist Matt da Silva urged people not to let up in their support of Assange, praising him as a crusader against government's efforts to manage and control the media, Buy Tramadol No Prescription.

—

Reconciling journalism and political views: What started a couple of weeks ago as yet another public radio conundrum regarding its employees and political opinions morphed into an interesting discussion about journalism and transparency. My Tramadol experience, Two public radio employees, Lisa Simeone of Soundprint and Caitlin Curran of WYNC's The Takeaway, were fired after taking part in Occupy Wall Street protests. Curran told her story at Gawker, and Brooke Gladstone, host of the NPR show On the Media, discussed NPR's policy in a live chat.

The Atlantic's Conor Friedersdorf argued that WNYC was wrong to fire Curran, buy Tramadol without prescription, pointing out that several NPR reporters have made essentially the same point she did in her protest sign, and have been praised for it. He and the Guardian's Dan Gillmor also made the case Buy Tramadol No Prescription, for doing away with the philosophy of viewlessness in the American press. As Gillmor put it, telling journalists they can't even hint at what they believe "puts a barrier between them and their audiences – a serious problem given that news and journalism are evolving from a lecture into a conversation." Though he wasn't discussing the public radio firings, Gawker's Hamilton Nolan did provide a counterargument, defending journalistic facelessness and an institutional writing style. Tramadol trusted pharmacy reviews, And as if on cue, former New York Sun editor Ira Stoll launched News Transparency, a site that lets people know about journalists' backgrounds as a kind of imposed transparency from the outside, as Poynter's Jeff Sonderman put it.

—

The Verge takes off: A new tech blog to watch: The sports blog network SB Nation launched a tech blog called The Verge this week, under the leadership of several former Engadget staffers. As part of the launch, SB Nation and The Verge will both fall under a new parent media called Vox Media, where can i buy cheapest Tramadol online. The site got some initial rave reviews over its updating story streams, something that SB Nation has been using for a while, Buy Tramadol No Prescription.

Business Insider has an interview with the folks behind the site, and the Lab's Justin Ellis talked about where SB Nation/Vox will go from here. The Lab's Joshua Benton also pulled three lessons for news orgs out of the site's development, emphasizing bold, tablet-style design, structured data, Tramadol class, and community.

—

Reading roundup: Tons of stuff going on this week. Here's the TL;DR version of the rest:

— Google began giving journalists photos next to their stories in Google News — but only if they have a Google+ account. Alexander Howard was OK with it Buy Tramadol No Prescription, , but Columbia's Emily Bell wasn't, calling it coercion and saying it only helped Google, not journalism.

— The St. Petersburg Times, a newspaper owned by the nonprofit Poynter Institute, announced it will change its name to the Tampa Bay Times on Jan. 1, order Tramadol online c.o.d, broadening its geographic focus. Poynter rounded up some of the reaction on social media and compared the decision to other recent newspaper name changes.

— Your weekly News Corp, Buy Tramadol No Prescription. phone hacking update: New documents released by a committee of Britain's Parliament revealed that a company attorney warned of a culture of hacking back in 2008. Here's the summary from News Corp.'s own Wall Street Journal and a blow-by-blow from the Guardian.

— As GigaOM's Colleen Taylor reported, Twitter has quietly unveiled new Top News and Top People search functions. Tramadol photos, Poynter's Jeff Sonderman looked at the effect it will have on publishers.

— Media analyst Frederic Filloux examined the sad state of web news design, and Amy Gahran of the Knight Digital Media Center said all the ugliness could help push users to the mobile web.

— The Guardian launched n0tice, their open community news platform. The Lab's Megan Garber took a look at the new site, and The Next Web's Martin Bryant examined it as a possible replacement for local newspapers.

— Finally, here's hoping this inspiring Lab post by Jacob Harris will forever put an end to the insipid question, "Will X save journalism?".

Similar posts: Order Cipro. Zoloft Price. Tramadol Mg. Buy Lipitor without prescription. Is Armour safe. Purchase Lipitor online.
Trackbacks from: Buy Tramadol No Prescription. Buy Tramadol No Prescription. Buy Tramadol No Prescription. Where to buy Tramadol. Canada, mexico, india. Tramadol forum.

[This review was originally posted at the Nieman Journalism Lab Diflucan Dosage, on June 10, 2011.]

Apple’s mobile Newsstand is a reality: When Steve Jobs makes an announcement, it’s a pretty good bet that whatever he introduces will be what the media-tech world is talking about for the next week (or month, or year). On Monday, Jobs had plenty to introduce — led by a new Mac operating system (Lion), mobile operating system (iOS 5), and a new cloud service to replace MobileMe (iCloud). Those developments have implications for several different aspects of news and media, Diflucan mg, and I’ll try to run down as many of them as I can.

The most direct impact will likely come from Newsstand, an app Jobs unveiled that will be similar to iBooks, providing a single place for all of a user’s magazine and newspaper app subscriptions.

TechCrunch called it evidence that Apple is emphasizing that the iPad is for reading, while GigaOM’s Mathew Ingram and the Guardian’s Jemima Kiss saw a trade-off for publishers: A simpler subscription interface (which likely means more renewals), but even more control for Apple. For consumers, as the Lab’s Andrew Phelps and Megan Garber noted, purchase Diflucan online no prescription, it’s the closest digital publishing has come to the traditional distribution model of regular home delivery.

Apple’s new operating systems will include a raft of upgrades, many of which overlap with existing third-party apps. The New York Times’ Bits blog has a good breakdown of what apps might be threatened, led by the reading-list creator Instapaper, as Apple will begin offering a similar basic function as part of Safari. Instapaper founder Marco Arment was understandably perturbed by the news, but later reasoned that the upgrade could make saving things to read later a built-in part of the workflow of millions of Apple users — and that if even a small percentage of them want a deluxe version of that service, Instapaper will still be in fine shape. The point was echoed by The Next Web’s Matthew Panzarino and by Andrew and Megan here at the Lab.

—

Apple eases up — kind of: Apple made another significant change this week, too, this one without an announcement, Diflucan Dosage. Order Diflucan online c.o.d, As MacRumors discovered yesterday, Apple quietly adjusted its policy on in-app subscriptions, allowing publishers to sell in-app subscriptions for whatever price they want (previously, they had to be at least as cheap as app subscriptions outside Apple’s store) and lifting the requirement that subscriptions must be offered within the app itself.

All Things Digital’s Peter Kafka has a good explanation of the change, noting that Apple may be allowing companies to circumvent its App Store, but it’s not going to let it be easy. (You still can’t, for example, Diflucan without a prescription, include in your app a “Buy” button pointing users to subscribe via your website.) Still, the lifting of the price restriction could be an encouragement for publishers because, as paidContent’s Staci Kramer pointed out, now they can raise prices to absorb Apple’s 30% revenue cut.

But that doesn’t mean publishers will end up taking advantage of their newfound freedoms. The Lab’s Joshua Benton argued that most publishers won’t, Rx free Diflucan, because customers will resist varied app prices and because Apple’s app purchasing system offers some significant value to publishers that might be worth its 30% cut. And media analyst Ken Doctor reminded us that Apple still holds just about all the cards in this hand.

Poynter’s Jeff Sonderman made an interesting observation: Apple seems to be using the adjusted guidelines to funnel app subscriptions into its new Newsstand. Newsstand’s likely prominence still leaves plenty of open questions for publishers (including the ones outlined earlier), Sonderman said.

—

The Financial Times hedges its bets on Apple: One publisher stated quite emphatically this week that it’s not going to play Apple’s game: The Financial Times unveiled a mobile web app intended as an alternative to Apple’s App Store-based apps.

By using an HTML5-based app, the FT can design a single app for any major mobile device and get around Apple’s 30 percent cut of app subscriptions, but its apps may get pulled from the App Store. Diflucan Dosage, (The next day, the FT responded to Apple’s new guidelines with what sounded like indignation, sounding as though they’ll charge forward.)

An FT exec told the Guardian that the app was something of a line in the sand, resulting from what he called a “Mexican standoff” with Apple. The move was heralded as a critical one in the tug-of-war between Apple and publishers: All Things Digital called it the first attempt by a major news org to create an HTML5 app that feels just like an App Store app, Diflucan street price, and paidContent said the move was “significant and brave,” especially since its Apple-native apps have been so successful.

Bobbie Johnson of GigaOM wondered if this would be the catalyst news orgs need to start standing up to Apple, and Ken Doctor said the FT’s main value would be in providing a counterweight to the Apple-centric market, as well as experiments for other news orgs to learn from. Benedict Evans, Diflucan cost, meanwhile, said the FT may have a dedicated readership to pull this off where other news orgs can’t.

There were a few voices pushing back against the “FT goes to war with Apple” narrative: Noting that the FT says it has no plans of leaving the App Store, the Lab’s Andrew Phelps argued that “FT’s web app could be less about shunning Apple and more about working with it: keeping one foot inside Apple’s garden, and the other outside.” Doctor talked about the FT’s strategy as a blueprint for news orgs to use Apple as Apple uses them.

And both Phelps and Poynter’s Jeff Sonderman noted that the FT’s not the first news org to try this approach, as NPR and others have dabbled in HTML5 apps before. U.K.-based journalist Kevin Anderson reviewed the app and concluded that HTML5 will soon be “the standard that enables the next wave of cross-platform innovation."

—

The metered model gets a closer look: Ever since early last year, when the New York Times announced its plans to charge for its website through a metered model, Diflucan canada, mexico, india, that form of online paid content has gotten far more attention than any other. This week, French media consultant Frederic Filloux offered a useful explainer for the model, detailing how it works, what goes into publishers’ decisions about how to implement them, Online buying Diflucan, and where they fit among other paid-content models. One of its major appeals, he argued, is that advertisers see visitors who have paid up as much more valuable, paying as much as a 30 percent premium to reach them.

Filloux presented the metered model as a way of combating the overreliance on one-time, fly-by web visitors by news sites, Diflucan Dosage. British journalist Kevin Anderson echoed those concerns, calling for news orgs to “move to more honest and realistic metrics” and separate out “bounce” visitors, or those who stay on the site for only a few seconds, from their traffic figures. Meanwhile, Filloux’s metered-model math didn’t sway GigaOM’s Mathew Ingram, Diflucan results, who said he still opposes it as a fundamentally backwards-facing strategy.

Another piece of paid-content news worth noting briefly: Outgoing Fox News personality Glenn Beck’s new Internet broadcast-style network will employ a monthly subscription fee. You can check out the commentary on his venture at Mediagazer.

—

A local reporting crisis: The U.S. Federal Communications Commission added fuel to the long-simmering discussion over the future of accountability reporting in a digital media environment this week, releasing a study finding that the U.S. faces a critical shortage of local reporting, leaving local governmental bodies with an alarming power to influence the news agenda without being checked.

As the Lab’s Megan Garber noted, Diflucan from mexico, its bleak picture of local reporting and many of its proposed solutions were nothing new, except for its recommendation that the government make efforts to funnel advertising into local media, rather than national. Gawker’s Hamilton Nolan said now is a ripe time Diflucan Dosage, for a local news reporting resurgence and urged young reporters to stay away from media centers like New York and flock to small towns instead, and the Atlantic Wire’s Adam Clark Estes looked at how to make that resurgence a reality.

—

A crackup at AOL?: Henry Blodget of Business Insider calculated a tidbit about the post-merger AOL which, if true, is pretty startling: It now has a larger editorial staff than The New York Times. But just because the new, content-oriented AOL is big doesn’t mean it’s stable. A few days earlier, Business Insider published an anonymous note by an AOL staffer painting a picture of a corporate culture marked by paranoia, buy Diflucan no prescription, dissension, and incompetence.

In a more thoroughly reported story, Forbes’ Jeff Bercovici found a similarly grim situation at AOL, revealing a misunderstanding on AOL’s part about how the Huffington Post’s business model works and a dysfunctional sales department, among other problems. Business Insider came back later in the week with a conversation with an anonymous Patch editor who described low morale, Diflucan dose, sagging ad sales, poor leadership and a clueless business model.

Gawker’s Ryan Tate combed through the two pieces for a good, quick rundown of the charges levied against Arianna Huffington, and the Atlantic Wire’s John Hudson also put together a good summary of what’s wrong.

—

Reading roundup: Whew. Here’s what else folks were talking about this week:

— We found out a bit more about the New York Times’ new executive editor, Jill Abramson. Here are profiles and interviews from the New York Observer, get Diflucan, Los Angeles Times, Guardian, Adweek, Low dose Diflucan, and Women’s Wear Daily. Don’t have time for all that, Diflucan Dosage. The Atlantic Wire has a good roundup.

— A new site worth keeping an eye on, especially for sports fans: Grantland, a project of ESPN columnist Bill Simmons, launched this week. Simmons has called it a Miramax to ESPN’s Disney, and former ESPNer Dan Shanoff is optimistic about its chances. Simmons said he’s not into chasing pageviews, and here at the Lab, Tim Carmody looked at Simmons’ effort to find success at the intersection of sports and pop culture.

— Also at the Lab, Justin Ellis took a look at Hacks/Hackers and the future of the niche Q&A site.

— The Knight Digital Media Center’s Amy Gahran suggested the “Lego approach” to storytelling as a way to add context and integration to journalism.

— Finally, one great practical piece and another one to think on. At the Columbia Journalism Review, Craig Silverman got some fantastic tips from various social media experts about how to verify information on social media, and NYU j-prof Jay Rosen took stock of where “pro-am journalism” is and where it’s headed.

Similar posts: Buy Armour No Prescription. Purchase Lipitor. Flagyl Mg. Bactrim photos. Effects of Retin A. Where can i buy Synthroid online.
Trackbacks from: Diflucan Dosage. Diflucan Dosage. Diflucan Dosage. Order Diflucan online overnight delivery no prescription. Diflucan samples. Australia, uk, us, usa.

—[This review was originally posted at the Nieman Journalism Lab Buy Cephalexin No Prescription, on Dec. 17, 2010.]

The media and WikiLeaks' uneasy coexistence: The current iteration of the WikiLeaks story is about to move into its fourth week, and it continues to swallow up most future-of-journalism news in its path. By now, it's branched out into several distinct facets, and we'll briefly track down each of those, but here are the essentials this week: If you want the basics, Cephalexin gel, ointment, cream, pill, spray, continuous-release, extended-release, Gawker has put together a wonderful explainer for you. If you want to dive deep into the minutiae, there's no better way than Dave Winer's wikiriver of relevant news feeds. Other good background info is this Swedish documentary on WikiLeaks, posted here in YouTube form.

The big news development this week was WikiLeaks founder Julian Assange's release from British jail on bail Thursday, Buy Cephalexin No Prescription. As blow-by-blow accounts of the legal situation go, Buy Cephalexin without prescription, you can't beat The Guardian's. Meanwhile, the U.S. government is trying to build a conspiracy case against Assange by connecting him more explicitly to Bradley Manning's leak, and Congress heard testimony on the subject Thursday.

— The first WikiLeaks substory is the ongoing discussion about the actions of the legions of web-based "hacktivists," led by Anonymous, making counterattacks on WikiLeaks' behalf, Cephalexin used for. Having gone after several sites last week (including one mistakenly Buy Cephalexin No Prescription, ), some activists began talking in terms of "cyber-war" — though GigaOM's Mathew Ingram cautioned against that type of language from all sides — and were urged on from jail by Assange. NYU professor Gabriella Coleman gave a glimpse into the inner workings of Anonymous, and they also drew plenty of criticism, too, from thinkers like British author Andrew Keen. Media consultant Deanna Zandt offered a thoughtful take on the ethics of cyber-activism.

— The second facet here is the emergence of Openleaks, Is Cephalexin safe, a leaking organization formally launched this week by WikiLeaks defector Daniel Domscheit-Berg as an alternative to Assange's group. As Domscheit-Berg explained to several outlets including Forbes, Openleaks will act as a more neutral conduit to leaks than WikiLeaks, which ended up publishing its leaks, something Openleaks won't do. Wired compared it with WikiLeaks' rejected 2009 Knight News Challenge proposal, in which it would have functioned primarily as an anonymous submission system for leaks to local news organizations, Buy Cephalexin No Prescription. Openleaks won't be the last, either: As The Economist noted, if file-sharing is any guide, Cephalexin coupon, we'll see scores of rivals (or comrades).

— The third story is the reaction of various branches of the traditional media, which have been decidedly mixed. WikiLeaks has gotten some support from several corners of the industry, including the faculty of the venerable Columbia School of Journalism, the press in Assange's native Australia, Cephalexin for sale, and Northeastern j-prof Dan Kennedy and numerous other British and American professors and journalists, both in The Guardian. But it's also been tweaked by others — New York Times editor Bill Keller said that if Assange is a journalist, "he's not the kind of journalist that I am."

Salon columnist Glenn Greenwald ripped what he called the mainstream media's "servile role" to the government in parroting its attitudes toward WikiLeaks, then later argued that the government's prosecution of WikiLeaks would be a prosecution of investigative journalism in general. Buy Cephalexin No Prescription, Likewise, Morris' Steve Yelvington listed five reasons the media hasn't shown outrage about the government's backlash against WikiLeaks, including the point that the segment of the American mainstream media concerned about national issues is a shell of its former self.

— All of this provided plenty of fodder for a couple of conferences on WikiLeaks, Internet freedom, and secrecy, what is Cephalexin. Last weekend, the Personal Democracy Forum held a symposium on the subject — you can watch a replay here, as well as a good summary by GRITtv and additional videos on the state of the Internet and online civil disobedience. Micah Sifry offered a thoughtful take on the event afterwards, saying that longings for a "more responsible" version of WikiLeaks might be naive: It's "far more likely that something far more disruptive to the current order--a distributed and unstoppable system for spreading information--is what is coming next," he wrote. Online buying Cephalexin hcl, And on Thursday, the Lab held its own one-day conference on journalism and secrecy that included keynotes by the AP's Kathleen Carroll and The Times' Bill Keller (who distanced himself from Assange but defended The Times' decision to publish). If you want to go deeper into the conversation at the conference, the #Niemanleaks hashtag on Twitter is a good place to start, Buy Cephalexin No Prescription.

—

Will the iPad eat into print?: The iPad news this week starts with the University of Missouri's Reynolds Journalism Institute, which released a study that suggests, based on survey data, that iPad news apps may cut into newspaper subscriptions by next year. There's a ton of other interesting data on how iPads are being used and how users are comparing them to print newspapers and newspaper websites, but one statistic — 58% of those who subscribe to a print newspaper and use their iPad for more than an hour a day planned to cancel their print subscription within six months — was what drew the headlines, buy generic Cephalexin. Alan Mutter said publishers have to like the demographics of the iPad's prime users, but have to wonder whether developing print-like iPad apps is worth it.

Several news organizations introduced new iPad apps this week, led by CNN. Poynter's Damon Kiesow talked to CNN Buy Cephalexin No Prescription, about the rationale behind its photo-oriented multitouch design, and MocoNews' Ingrid Lunden looked at why CNN might have made their app free. Steve Safran of Lost Remote liked the app's design and sociability. Also, Order Cephalexin online overnight delivery no prescription, the New York Daily News launched a paid (though cheaper than the New York Post) app, and Harper's added its own as well.

Meanwhile, Flipboard, the inaugural iPad app of the year, launched a new version this week. Forbes' Quentin Hardy talked to Flipboard's CEO about the vision behind the new app, and The Wall Street Journal wrote about innovative iPad news apps in general, cheap Cephalexin. The Washington Post's Justin Ferrell talked to the Lab's Justin Ellis about how to design news apps for the iPad, Buy Cephalexin No Prescription. In iPad advertising, Apple launched its first iAd, which seems to be essentially a fully formed advertisement app. One iPad app that's not coming out this week: Rupert Murdoch's "tablet newspaper" The Daily, whose launch has reportedly been postponed until next year.

—

Looking ahead to 2011: We're nearing the end of the December, Where can i cheapest Cephalexin online, which means we're about to see the year-end reviews and previews start to roll in. The Lab got them kicked off this week by asking its readers for predictions of what 2011 will bring in the journalism world, then publishing the predictions of some of the smartest future-of-news folks in the room. Buy Cephalexin No Prescription, All of the posts are worth checking out, but there are a few I want to note in particular — The AP's Jonathan Stray on moving beyond content tribalism ("a news product that refuses to provide me with high-quality filtering and curation of the rest of the world’s information will only ever be an endpoint"), NPR's Matt Thompson on instant speech transcription ("the Speakularity"), tech pioneer Dave Winer on adjusting to the new news distribution system ("That’s the question news people never seem to ask. How can we create something that has a market?"), and a couple of paid-content predictions on The New York Times and by Steven Brill (who has skin in the game).

The prediction post that generated the most discussion was NYU professor Clay Shirky's piece on the dismantling of the old-media syndication system. GigaOM's Mathew Ingram expanded on the idea, connecting it explicitly to Google News and the Associated Press, taking Cephalexin, and asking, "In a world where the power to syndicate is available to all, does anyone want what AP is selling?" USC's Pekka Pekkala explained why he sees this as a positive development for journalists and niche content producers.

As if on cue, Thomson Reuters announced the launch of its new American news service, one that seems as though it might combine traditional news syndication with some elements of modern aggregation. Media analyst Ken Doctor gave some more details about the new service and its deal with the Tribune Co., and Gawker's Hamilton Nolan was skeptical of this potential new direction for newswires, Buy Cephalexin No Prescription. Cephalexin natural, —

Reading roundup: A few good pieces before I send you on your way:

— First, one quick bit of news: The social bookmarking service Delicious will reportedly be shut down by Yahoo. Here's a short ode from ReadWriteWeb and a list of alternatives from The Next Web.

— At the London Review of Books, British journalist John Lanchester has written an essay making a case for why and how the newspaper industry needs to charge for news online. Anti-paywall folks aren't going to be crazy about it, but it's far from the stereotypical revanchist "Make 'em pay, just 'cause they should" pro-pay argument: "Make the process as easy as possible, no prescription Cephalexin online. Buy Cephalexin No Prescription, Make it invisible and transparent. Make us register once and once only. Walls are not the way forward, but walls are not the same thing as payment, and without some form of payment, the press will not be here in five years’ time."

— A couple of close looks at what news organizations are doing right: The Atlantic's web transformation and tips on multimedia storytelling from NPR's acclaimed Planet Money.

— A North Carolina j-prof and Duke grad student came together(!) to urge news organizations to incorporate more of the tenets of citizen journalism. They have a few specific, practical suggestions, too.

— British journalist Adam Westbrook gave his goodbye to mainstream media, making a smart case that the future lies outside its gates.

— Finally, Jonathan Stray, an AP editor and Lab contributor, has a brilliant essay challenging journalists and news organizations to develop a richer, more fully formed idea of what journalism is for. It may be a convicting piece, but it offers an encouraging vision for the future — and the opportunity for reform — too.

Similar posts: Flagyl For Sale. Bactrim Mg. Lipitor Cost. Kjøpe Lipitor på nett, köpa Lipitor online. Zoloft pics. Canada, mexico, india.
Trackbacks from: Buy Cephalexin No Prescription. Buy Cephalexin No Prescription. Buy Cephalexin No Prescription. Cephalexin forum. Order Cephalexin from United States pharmacy. Buy Cephalexin online no prescription.

[This review was originally posted at the Nieman Journalism Lab Tramadol For Sale, on Sept. 10, 2010.]

An uneasy move into the world of web metrics: As CUNY j-prof C.W. Anderson declared on Twitter, this was "obviously the week of news metrics," so it's probably best to start there. Australia, uk, us, usa, The discussion was kicked off Monday by a New York Times feature on traditional news organizations beginning to pay more attention to their online traffic numbers — something most other websites have been doing religiously for years, but a relative novelty for traditionally one-way institutions such as the Times and The Washington Post. The Times' Jeremy Peters painted a picture of the Post's newsroom that didn't look all that different from Gawker Media in this respect: Traffic data gets displayed on a screen in the newsroom, emailed daily to staff members, and has played a role in staff-cutting decisions.

Still, editors at America's most prominent newspapers (the Times, the Post, The Wall Street Journal, and The Los Angeles Times were the four examined) were careful to note (somewhat dubiously) that they don't let that traffic dictate what they write about, Tramadol For Sale. The Post's media critic, Howard Kurtz, herbal Tramadol, weighed in on the phenomenon with some concern, pondering the balance between pushing for traffic and protecting a storied brand like the Post's or the Times'. "They can't simply abandon serious news in favor of the latest wardrobe malfunction without alienating some of their longtime readers," he said of the two papers. "What they gain in short-term hits would cost them in long-term reputation."

Naturally, Ordering Tramadol online, Gawker tweaked Kurtz for his paternal unease about the issue, mocking the idea that knowing and adjusting for what readers care about represents a threat to journalism. Econsultancy's Patricio Robles remarked that the Times didn't find any evidence of major news organizations being corrupted by the use of their traffic numbers and wondered why newspapers don't go further, like testing multiple versions of the same story. Tramadol For Sale, Meanwhile, Columbia researchers released a study that found that news organizations use metrics that vary widely in their measurements of online traffic, leading to confused editors and hesitant advertisers. The Columbia Journalism Review adapted the study into an article by Lucas Graves on the web's too-much-information problem and its effect on news organizations: "The Web has been hailed as the most measurable medium ever, and it lives up to the hype. The mistake was to assume that everyone measuring everything would produce clarity." On the other hand, online buy Tramadol without a prescription, Graves said, news decisions have been made easier in other media (like, say, TV) where metrics were not necessarily more accurate, but more unanimous. Tramadol description, —

Google Instant's impact on search: This week, Google unveiled another tool that might eventually have a significant effect on that web traffic: Google Instant, a change to its web search function (though it's coming to browsers soon) that allows users to see results for predicted searches as they type. Essentially, it takes Google's autocomplete feature and shows the results of those possible searches as well as the search terms themselves. Here, let Search Engine Land explain it to you — they're good at this, and they have pictures, Tramadol For Sale.

Google is selling this feature on the idea that it makes searching faster, though like Scott Rosenberg, Tramadol overnight, I'm not too interested in that aspect. (As TechCrunch's Erick Schonfeld pointed out, the bigger change is in the volume of search results you'll be processing, not the speed with which you'll get them.) The more significant issue is what this might do to industry of search-engine optimization. Google noted that websites and keyword ads will see some fluctuations in the number of impressions they get, Tramadol without prescription, and The Guardian has asuperb explanation of how SEO works and what Google Instant might do to it.

PR expert Steve Rubel was the first to speculate that Google Instant could kill SEO, arguing that it will serve as feedback that allows people to change their searches in real-time, rejecting inadequate search results and personalizing the web for themselves. "Google Instant means no one will see the same web anymore, making optimizing it virtually impossible," he said. (The Guardian Tramadol For Sale, also noted that if users are signed into their Google account, their results will also be personalized based on their web history.)

Quite a few people leaped to refute Rubel's point, with ReadWriteWeb quoting a marketer who speculated that top search results and "long-tail search" would gain even more value. Other arguments for the continued existence of SEO: as long as people are using search engines to find information, Tramadol used for, that information will need to be optimized (Search Engine Land); Google's search is still only as good as the content it finds (Econsultancy); SEO experts have already been planning around personalized search and Google Suggest (Vanessa Fox); and they'll continue to adapt to this increased personalization (Google's Matt Cutts).

A couple of people made the interesting case that Google Instant will actually reduce the individuality in web search: Searchers will stop once they see results for a popular search that's close enough to what they were looking for, the argument goes. Web entrepreneur Bob Warfield put the point well: "Instant Search will substitute popular searches for those individually created. More people will be driven off the back roads search trails and onto the superhighways that lead to whomever controls the first few search results connected to the Instant Searches Google is recommending at the time." It's a possibility that could have damaging implications for serendipity in finding alternative news voices online, too. Tramadol pics, —

NPR's targeted local push: We've been hearing for a while about NPR's new local-news web initiative, and this week NPR formally launched it as The Argo Network, a set of a dozen websites run by public-radio stations on specific local issues. PaidContent's Staci Kramer took a close look at what the network's sites look like and the thinking behind them, with NPR execs noting that the network's reporter-bloggers will take a web-first approach and that the underlying philosophy isn't much different from AOL's Patch hyperlocal-news project, Tramadol For Sale. The funding is, however; the project has $3 million to last it through next year, compared with Patch's gobs o' cash.

SF Weekly's Lois Beckett talked to NPR's Matt Thompson about the reporting ethos of the project: A focus on a passionate niche audience, Tramadol interactions, curation and community-building, and an emphasis on the news stream and news developments' context within larger stories. Here at the Lab, Ken Doctor was impressed by the indications that the project will be able to create and multiply audiences for itself and its member stations. "Like Silicon Valley startups, the effort is about building a product that seems to meet a clear audience need, About Tramadol, building that audience — and then finding a sustainable business model," he wrote. "That’s what has built companies for decades in the valley, and it’s in contrast to how much of the journalism business has long gotten funded."

—

Apple's app police and news: Apple issued revised guidelines for its App Store this week, summarized nicely at Daring Fireball and a little more comically at TechCrunch. You can find plenty of commentary Tramadol For Sale, on this from the developers' perspective, but there's a significant journalistic angle to this as well, as Apple's app store policies have generated a little bit of consternation in the past year.

Apple is using the "we'll know it when we see it" approach to determining what's inappropriate content, which Scott Rosenberg saw as pretty problematic for a platform that Apple's billing as the New Newsstand, Tramadol price, coupon. After running down excerpts from the guidelines in which Apple threatens imposing new rules on the spot and retaliating against developers who give them bad press, Rosenberg wrote, "Now read these questions from the perspective of a writer or journalist or publisher, not a software developer, and tell me they don’t give you the willies."

The Lab's Joshua Benton also examined Apple's rules from a news perspective, Tramadol reviews, expressing frustration at its limitation of its new political satire exception to professionals. "Defining who is a 'professional' when it comes to opinion-sharing is sketchy enough, but when it includes political speech and the defining is being done by overworked employees of a technology company, it’s odious," Benton said.

—

Reading roundup: Lots of interesting smaller discussions to poke around in this week. Here's a sampling:

— Two must-read pieces of advice for new journalists and journalism students: Jay Rosen's adaptation of his lecture last week (also linked to here last week) on the new users of journalism and how to serve them best, and Mark Briggs' case for studying journalism right now, Tramadol australia, uk, us, usa.

— We got the second quarter's ad numbers for newspapers, which were either a relief (according to the Newspaper Association of America) or another in a seemingly neverending series of low points (according to industry analyst Alan Mutter), Tramadol For Sale. In other depressing statistics, a report found that mainstream journalism jobs in the U.K. have decreased by nearly a third in the last decade.

— At TechCrunch, online video executive Ashkan Karbasfrooshan made his case against content farms from a marketing perspective ("should content producers really be conveying the fact that we’re cheap dates?"), Tramadol online cod, while web veteran John Battelle wrote a long, thoughtful post on whether one of those content farms, Demand Media, can adapt to an increasingly social web.

— New York Times Publisher Arthur Sulzberger Jr. urged media companies to be risk-takers in charging for content and finding sustainable business models online. Wikipedia founder Jimmy Wales, meanwhile, said he sees much more of a future in paid mobile apps than in online news paywalls.

— Finally, two longer pieces to spend some time with this weekend: The Lab published a version of Kimberley Isbell's fabulously helpful primer on aggregation and copyright law, and TechCrunch's Paul Carr wrote an ode to Adam Penenberg's hybrid breaking-news/long-form journalism on Twitter. Great stuff, both.

Similar posts: Purchase Bactrim. Glucophage Cost. Flagyl Cost. Doses Zoloft work. Ordering Bactrim online. Cephalexin recreational.
Trackbacks from: Tramadol For Sale. Tramadol For Sale. Tramadol For Sale. Tramadol from mexico. Buy Tramadol online cod. Tramadol price.

[This review was originally posted at the Nieman Journalism Lab Retin A Mg, on May 21, 2010.]

Should Facebook be regulated?: It's been almost a month since Facebook's expansion of Open Graph and Instant Personalization, and the concerns about the company's invasion of privacy continue to roll in. This week's appalling example of how much Facebook information is public comes courtesy of Openbook, a new site that uses Facebook's API to allow you to search all public Facebook updates. (Of course, you'll find similarly embarrassing revelations via a Twitter search, but the point is that many of these people don't know that what they're posting is public.)

We also got another anti-Facebook diatribe (two, Buy Retin A no prescription, actually) from a web luminary: Danah Boyd, the Microsoft researcher and social media expert. Boyd, who spends a lot of time talking to young people about social media, noted two observations in her first post: Many users' mental model of who can see their information doesn't match up with reality, and people have invested so much time and resources into Facebook that they feel trapped by its changes. In the second post, Boyd proposes that if Facebook is going to refer to itself as a "social utility" (and it's becoming a utility like water, Retin A blogs, power or the Internet, she argues), then it needs to be ready to be regulated like other utilities.

The social media blog Mashable has chimed in with a couple of defenses of Facebook (the web is all about sharing information; Facebook has normalized sharing in a way that users want to embrace), but the din has reached Facebook's ears. The Wall Street Journal reported that the issue has prompted deep disagreements and several days of discussions at Facebook headquarters, What is Retin A, and a Facebook spokesman said the company is going to simplify privacy controls soon.

Meanwhile, tech investor and entrepreneur Chris Dixon posited that Facebook is going to use its web-wide Like button to corner the market on online display ads, similar to the way Google did with text ads, Retin A Mg. Facebook also launched 0.facebook.com, a simple mobile-only site that's free on some carriers, leading Poynter's Steve Myers to wonder if it's going to become the default mobile web for feature, or "dumb" phones. But The New York Times argued that when it comes to social data, Facebook still can't hold a candle to the good old-fashioned open web, australia, uk, us, usa.

—

Are iPad apps worth it?: The iPad's sales haven't slowed down yet — it's been projected to outsell the Mac, and one in five Americans say they might get one — but there are still conflicting opinions over how deeply publishers should get involved with it. Slate Group head Jacob Weisberg was the latest to weigh in, arguing that iPad apps won't help magazines and newspapers like they think it will. Retin A Mg, He makes a couple of arguments we've seen several times over the past month or two: App producers are entering an Apple-controlled marketplace that's been characterized by censorship, and apps are retrograde attempts to replicate the print experience.

"They're claustrophobic walled gardens within Apple's walled garden, Buy Retin A without a prescription,  lacking the basic functionality we now expect with electronic journalism: the opportunity to comment, the integration of social media, the ability to select text and paste it elsewhere, and finally the most basic function of all: links to other sources," Weisberg says. GQ magazine didn't get off to a particularly encouraging start with its iPad offerings, selling just 365 copies of its $2.99 Men of the Year iPad issue, real brand Retin A online.

A few other folks are saying that the iPad is ushering in fundamental changes in the way we consume personal media: At Ars Technica, Forrester analyst Sarah Rotman Epps notes that the iPad is radically different from what people say they want in a PC, but they're still more than willing to buy it because it makes complex computing simple. (The term Forrester is using to describe the tablet era, curated computing, Retin A description, seems like a stretch, though.) Norwegian digital journalist John Einar Sandvand offers a similar take, saying that tablets' distinctive convenience will further weaken print newspapers' position. And the Lab's Josh Benton says the iPad could have an effect on the way we write, too, Retin A Mg.

—

Slipping through the Times' and WSJ's paywalls: New York Times editor Bill Keller gave an update late last week on the plans for his paper's much-anticipated paywall — he didn't tell us anything new, unless you count the news that the wall will start in January 2011, rather than just "next year." But in reiterating the fact that he wasn't breaking any news, he gave Media Matters' Joe Strupp a bit of a clearer picture about how loose the Times' metered model will be: "Those who mainly come to the website via search engines or links from blogs, Retin A treatment, and those who only come sporadically -- in short, the bulk of our traffic -- may never be asked to pay at all," Keller wrote.

In the meantime, digital media consultant Mark Potts found another leaky paywall at The Wall Street Journal. Fast shipping Retin A, Potts canceled his WSJ.com subscription (after 15 years!) and found that he's still able to access for free almost everything he had previously paid for with only a few URL changes and the most basic of Google skills. And even much of that information, he argues, is readily available from other sources for free, damaging the value of the venerable Journal paywall. "Even the Journal can't enforce the kind of exclusivity that would make it worth paying for—it's too easy to look elsewhere," Potts writes. Retin A Mg, Another Times-related story to note: The paper's managing editor for news, Jill Abramson, will leave her position for six months to become immersed in the digital side of the Times' operation. The New York Observer tries out a few possible explanations for the move, Retin A recreational.

—

Going all-in on digital publishing: Speaking of immersion, two publishers in the past two weeks have tried a fascinating experiment: Producing an issue entirely through new-media tools. The first was 48 Hours, a new San Francisco-based magazine that puts together each issue from beginning to end in two days. The magazine's editors announced a theme, Retin A pics,  solicited submissions via email and Twitter, received 1,500 submissions, then put together the magazine, all in 48 hours. Several who saw the finished product were fairly impressed, but CBS's lawyers were a little less pleased about the whole '48 Hours' name, Retin A Mg. Gizmodo had a Q&A with the mag's editors (all webzine vets) and PBS MediaShift and the BBC took a closer look at the editorial process.

Second, effects of Retin A, the Journal Register Co. newspaper chain finished the Ben Franklin Project, an experiment in producing a daily and weekly newspaper and website using only free, web-based tools. Two small Ohio newspapers accomplished the feat this week, Retin A dose, and Poynter's Mallary Jean Tenore took a look inside the effort. Retin A Mg, What she uncovered should be an inspiration for people looking to implement change in newsrooms, especially ones that might be resistant to digital media. A quote from the daily paper's managing editor sums it up: "When we started out, we said, 'We're going to do what. How are we going to do this?' Now we're showing ourselves that we can operate in a world that, even six months ago, used to be foreign to us."

—

Reading roundup: This week, Retin A pharmacy, I've got two developments and a handful of other pieces to think on:

— Yahoo bought the online content producer Associated Content for $100 million this week. News business analyst Ken Doctor examined what this deal means for Yahoo (it's big, he says), and considers the demand-and-advertising-driven model employed by Associated Content and others like Demand Media.

— If you follow NYU professor Jay Rosen on Twitter, Retin A online cod, you've heard a ton about fact-checking over the past couple of months. A couple more interesting tidbits on the subject this week: Fact-checks are consistently the AP's most popular pieces online, and Minnesota Public Radio has unveiled PoliGraph, its own fact-checking effort, Retin A Mg.

— Poynter's Rick Edmonds compares two of the more talked-about local news startups launching this summer, Washington D.C.'s TBD and Hawaii's Honolulu Civil Beat. He's got some great details on both. Poynter also put together a list of 200 moments over the last decade that transformed journalism.

— If you're up for a quick, deep thought, the Lab's Josh Benton muses on the need for news to structure and shrink its users' world. "I think it’s journalists who need to take up that challenge," he says, "to learn how to spin something coherent and absorbing and contained and in-the-moment and satisfying from the chaos of the world around us."

— And once you're done with that, head into the weekend laughing at the Onion's parody of newspapers' coverage of social media startups.

Similar posts: Zoloft Price. Tramadol Mg. Cephalexin Cost. Buy Lipitor without prescription. Is Armour safe. Purchase Lipitor online.
Trackbacks from: Retin A Mg. Retin A Mg. Retin A Mg. Retin A without a prescription. After Retin A. Online buying Retin A.